Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

New study reveals best dosage for ADHD medications

Written by | 24 May 2026

Researchers have identified the best dosage for each ADHD medication using data from thousands of people with the condition. A new study published today [14 May] in The Lancet… read more.

No clear link between common antidepressant use in pregnancy and autism or ADHD in children, finds most comprehensive study to date

Written by | 23 May 2026

Current evidence does not support a causal link between the use of almost all antidepressants during pregnancy and an increased risk of neurodevelopmental disorders, including autism and attention-deficit/hyperactivity… read more.

Childhood sexual abuse linked to cancer diagnosis in adults age 65 and older

Written by | 25 Apr 2026

People who have experienced childhood sexual abuse have twice the odds of receiving a cancer diagnosis at age 65 or older compared to others who have not experienced… read more.

Behind Alzheimer’s care: Study reveals hidden burden and unmet needs of caregivers

Written by | 4 Apr 2026

A new study reveals that family caregivers of Alzheimer’s patients in Oman face significant unmet needs, ranging from limited knowledge about the disease to high psychological stress and… read more.

No evidence to suggest medicinal cannabis is effective for depression, anxiety or PTSD: research

Written by | 22 Mar 2026

A landmark Lancet Psychiatry paper published today – the largest-ever review of the safety and efficacy of cannabinoids across a range of mental health conditions – found no evidence that medicinal cannabis is… read more.

No overdiagnosis of ADHD, say experts

Written by | 14 Mar 2026

Experts are warning that far from being over diagnosed, people with ADHD are waiting too long for assessment, support and treatment. In a paper, published today in the British… read more.

CHMP adopts negative opinion for iloperidone in schizophrenia and bipolar I disorder – Vanda Pharmaceuticals

Written by | 9 Mar 2026

The EMA has recommended the refusal of the marketing authorisation for Iloperidone Vanda Pharmaceuticals, a medicine intended for the treatment of schizophrenia and manic or mixed episodes associated… read more.

Off-label antipsychotic use widespread among older adults, study finds

Written by | 28 Feb 2026

A large registry study in Finland by the University of Oulu and the University of Eastern Finland shows that many older adults receive antipsychotic medications for purposes other… read more.

Why a life-threatening sedative is being prescribed more often for seniors

Written by | 23 Jan 2026

When agitated dementia patients wander or shout through the night, families and caregivers understandably feel the need to treat this frightening and potentially dangerous behavior.  Antipsychotic medications are… read more.

The Lancet Psychiatry: Slow tapering plus therapy most effective strategy for stopping antidepressants, finds major meta-analysis

Written by | 28 Dec 2025

For adults who have recovered from depression with the help of antidepressants, gradually reducing medication together with psychological support appears to be as effective as remaining on antidepressants… read more.

Screen time linked to ADHD symptoms

Written by | 9 Dec 2025

Children who spend longer looking at screens have more severe attention-deficit/hyperactivity disorder (ADHD) symptoms, according to Japanese scientists who studied brain development and behavioural issues. The study found… read more.

Artificial intelligence can improve psychiatric diagnosis

Written by | 23 Nov 2025

Large language models can help improve questionnaires used to diagnose mental illness by optimizing symptom generalizability and reducing redundancy. They can even contribute to new conceptualizations of mental… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.